The authors concluded that the genetic variations in the UCP2-UCP3 gene cluster may act as a modifier increasing serum lipid levels and indices of abdominal obesity and may thereby also contribute to the metabolic aberrations observed in obesity and DM2. The gene discussed is UCP3; the disease is obesity disorder.